Recap: Corcept Therapeutics Q4 Earnings

Corcept Therapeutics CORT reported its Q4 earnings results on Tuesday, February 15, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Corcept Therapeutics beat estimated earnings by 66.67%, reporting an EPS of $0.35 versus an estimate of $0.21.

Revenue was up $13.09 million from the same period last year.

Last quarter the company beat on EPS by $0.1, which was followed by a 10.14% increase in the share price the next day.

Here's a look at Corcept Therapeutics's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	0.2	0.16	0.21	0.19
EPS Actual	0.3	0.30	0.20	0.27
Revenue Estimate	97.19M	86.84M	91.81M	87.77M
Revenue Actual	96.13M	91.59M	79.44M	85.73M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar